Almujtama Alraida Medical Co.
9592.SRSAUHealthcare● Active
$24.60
+$1.10(+4.68%)
Market Cap$233700000
P/E Ratio—
52W High$33.5
52W Low$22
Almujtama Alraida Medical Co.（9592.SR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · 9592.SR · 截至 2026-06-15
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.45B | $0.43B | $0.41B | $0.37B | $0.30B |
| Cost of Revenue | $0.30B | $0.29B | $0.28B | $0.27B | $0.24B |
| Gross Profit | $0.15B | $0.14B | $0.13B | $0.10B | $0.06B |
| Gross Margin %(computed) | 32.93% | 32.99% | 31.69% | 26.34% | 20.23% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Total Operating Expenses | $0.14B | $0.13B | $0.12B | $0.07B | $0.05B |
| Operating Income | $0.01B | $0.01B | $0.01B | $0.03B | $0.01B |
| Operating Margin %(computed) | 2.36% | 2.16% | 3.42% | 7.00% | 3.26% |
| Interest Income | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.01B | $0.01B | $0.02B | $0.01B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.01B | $0.01B | $0.01B | $0.02B | $0.01B |
| Net Margin %(computed) | 1.85% | 1.84% | 2.79% | 5.20% | 2.56% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.88 | $0.83 | $1.20 | $2.01 | $0.82 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.01B | $0.06B | $0.05B | $0.05B | $0.03B |
| EBITDA Margin %(computed) | 2.36% | 13.62% | 12.40% | 13.01% | 11.34% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · SAR · B
深入了解Almujtama Alraida Medical Co.
关于Almujtama Alraida Medical Co.（9592.SR）损益表
Almujtama Alraida Medical Co.（9592.SR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，9592.SR实现营收$0.45B，毛利润$0.15B（毛利率32.93%），净利润$0.01B（净利率1.85%）。
常见问题
9592.SR · 4 问Almujtama Alraida Medical Co.（9592.SR）2025财年营收为$0.45B，同比up5.6%。
9592.SR revenue9592.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15